tiprankstipranks
Eterna Therapeutics (ERNA)
NASDAQ:ERNA
US Market
ERNA
Eterna Therapeutics
RESEARCH TOOLSreports
Want to see ERNA full AI Analyst Report?

Eterna Therapeutics (ERNA) Income Statement

307 Followers

Eterna Therapeutics Income Statement

Last quarter (Q1 2026), Eterna Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Eterna Therapeutics's net income was $-5.51M. See Eterna Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 0.00$ 582.00K$ 68.00K$ 0.00$ 0.00
Gross Profit
$ 0.00$ 486.00K$ -168.00K$ 0.00$ 0.00
Operating Expenses
$ 9.32M$ 16.16M$ 20.97M$ 33.22M$ 113.73M
Depreciation and Amortization
$ 263.00K$ 1.64M$ 1.12M$ 497.00K$ 459.00K
EBITDA
$ -13.84M$ -36.12M$ -19.93M$ -24.01M$ -121.95M
Operating Income
$ -9.32M$ -15.67M$ -21.14M$ -33.22M$ -113.73M
Other Income/Expenses
$ -4.81M$ -28.84M$ -536.00K$ 8.68M$ -8.75M
Pretax Income
$ -14.13M$ -44.51M$ -21.67M$ -24.53M$ -122.48M
Net Income
$ -14.08M$ -44.54M$ -21.67M$ -24.58M$ -122.55M
Per Share Metrics
Basic EPS
$ -56.00$ -39.25$ -102.00$ -201.50$ -1.42K
Diluted EPS
$ -56.00$ -39.25$ -102.00$ -201.50$ -1.42K
Weighted Average Shares Outstanding
 252.28K 1.14M 212.56K 122.04K 86.60K
Weighted Average Shares Outstanding (Diluted)
 252.28K 1.14M 212.56K 122.04K 86.60K
Currency in USD

Eterna Therapeutics Earnings and Revenue History